Navigation Links
Global Markets for Intravascular Ultrasound Technology (IVUS) Products to Reach $702 Million by 2017: BCC Research
Date:8/11/2013

(PRWEB) August 11, 2013

According to a new technical market research report, The Global Market for Intravascular Ultrasound Tools and Ancillary Equipment (Report code: HLC145A) from BCC Research (http://www.bccresearch.com), the global market for intravascular ultrasound technology products is projected to reach $483.7 million in 2012. BCC Research expects the market to reach $702 million by 2017, and register a five-year compound annual growth rate (CAGR) of 7.7% for the period 2012 to 2017.

Intravascular ultrasound (IVUS) is an imaging technology/methodology that enables viewing of arteries from inside out by generating real-time, cross-sectional images. Intravascular ultrasound imaging technology (IVUS) holds enormous potential in terms of its ability to address unmet requirements in the earlier detection and intervention of coronary artery diseases. Moreover, the popularity of this technology has surged due to its proven advantages (as indicated by some international clinical studies) over traditional angiography. The use of IVUS in left main disease, chronic total occlusion, lower limb peripheral artery diseases, and for guiding angioplasty are some of the key opportunity areas for this technology.

However, while an aging population and rising chronic disease (such as cardiac disease) population is driving the market’s growth, the high cost of IVUS devices/products coupled with the growing need of cost-effective treatment worldwide is restricting its market growth. As a result, IVUS is still an underutilized and underpenetrated technology, whose real potential is yet to be exploited.

In terms of market maturity standards, IVUS is not a mature technology (except in Japan). On worldwide terms, it is experiencing slow-to-moderate growth and is yet to be universally adopted. The Japanese market for IVUS products, as a segment, was valued at $176.1 million in 2012. This market is expected to reach $257.4 million in 2017 and register a CAGR of 7.9%. The U.S. market for IVUS products was valued at $168.7 million in 2012 and is expected to reach $238 million in 2017, to register a CAGR of 7.1%.

According to BCC Research, product launches, partnerships, collaborations and agreements, and geographic/sales expansion are some of the key growth strategies adopted by market players. The report further states, the IVUS market as an investment worthy area with reference to the growth of positive clinical data, product innovations and underexploited potential.

This study examines the issues that are driving and constraining the growth of the IVUS market. Based on both quantitative and qualitative data, this report provides market participants with insights for understanding the current and changing IVUS market outlook. The data provided in this report can help users understand the market segments (products, applications and end users) that are expected to grow at higher rates, and study the factors that driving and restricting growth, and examine the key opportunity areas for this technology.

This report will be of interest to IVUS product developers and manufacturers, IVUS market start-ups, academic and commercial research organizations, consulting firms, and medical imaging market information database developers.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11010232.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. OMICS Mission to Promote Young Talents in Science to Meet the Current Global Challenges
2. Global Vaccine Market Trends and Disease Indications Analysis with 2022 Forecasts in New Research Report at RnRMarketResearch.com
3. Coronary Stent Industry 2015 & 2017 Forecasts for China & Global Markets in New Research Reports at ReportsnReports.com
4. Global Spa & Wellness Summit Unveils 2013 Conference Agenda
5. Global & China Monoclonal Antibody Market Analysis and 2017 Forecasts in New Research Report at RnRMarketResearch.com
6. Global and China Human Vaccine Market Analysis & 2017 Forecasts in New Research Report at RnRMarketResearch.com
7. Global Theranostic Nanomaterial Market To Reach $188 Billion By 2017: BCC Research
8. Global Medical Markets Fact Book 2013 - Worldwide Industry Share,Size,Trends,Analysis And Growth Research Report Available at MarketResearchReports.Biz
9. LDM Global to Host Decadent VIP After Party at ILTA Conference
10. Global Oncology Biomarkers Market to Reach US $9.5 Billion by 2014 at a CAGR of 18.1% - New Report by MarketsandMarkets
11. InnFocus, Inc. Receives IDE Approval of its Glaucoma Device and Secures Major Financing Led by HOYA Group, a Global Leader in Ophthalmology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... Dr. ... New York, has recently begun offering three new minimally invasive procedures to patients ... procedures and reducing downtime, Dr. Rubinstein is excited to bring microneedling, microneedling facials, ...
(Date:6/23/2017)... ... June 23, 2017 , ... Goodcents Deli Fresh Subs today announced the opening ... 4210 SW 21st St. Topeka, Kan. 66604 (near 21st and Gage). It is owned ... owns three other locations in the Topeka and Bonner Springs, Kan. area. , ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... ... Breast Cancer Conference from Sept. 18 to 20. , The two-day conference is ... subtype with the goal of improving patients’ lives and eliminating racial breast cancer-related ...
(Date:6/23/2017)... ... June 23, 2017 , ... PureLife Dental is pleased to announce ... for CDA members. As part of the amalgam separator endorsement, all CDA members may ... than $400 off the retail value. This partnership between PureLife and CDA is especially ...
(Date:6/23/2017)... ... June 23, 2017 , ... Ulster University, Magee Campus ... from 9 am to 3 pm to present to graduate students exciting new and ... an original curriculum project led by The Health Improvement Service of the Western Health ...
Breaking Medicine News(10 mins):
(Date:6/5/2017)... The Cincinnati location of ... (NYSE: DPLO), has been awarded a Top Workplaces 2017 ... Results are based on an employee survey administered by WorkplaceDynamics, ... improvement. The survey measures several aspects of workplace culture, including ... ...
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
(Date:6/1/2017)... BELL, Pa. , June 1, 2017 ... (PRN) and Veterinarian Recommended Solutions (VRS), and KD Pharma ... investment in Nutriceutical Holdings by KD Pharma Group. KD ... Holdings with the option to acquire the entire company. ... partner in KD. They are committed to growing the ...
Breaking Medicine Technology: